{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:10:32Z","timestamp":1780985432444,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00105-020-04680-6","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:02:56Z","timestamp":1599138176000},"page":"741-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Melanokortinpeptide","Melanocortin peptides"],"prefix":"10.1007","volume":"71","author":[{"given":"Markus","family":"B\u00f6hm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"4680_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/jid.2012.59","volume":"32","author":"M Auriemma","year":"2012","unstructured":"Auriemma\u00a0M, Brzoska\u00a0T, Klenner\u00a0L (2012) \u03b1\u2011MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation. J\u00a0Invest Dermatol 32:1814\u20131824","journal-title":"J Invest Dermatol"},{"key":"4680_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/a-0804-2715","volume":"127","author":"A Barthel","year":"2019","unstructured":"Barthel\u00a0A, Benker\u00a0G, Berens\u00a0K et\u00a0al (2019) An update on Addison\u2019s disease. Exp Clin Endocrinol Diabetes 127:165\u2013175","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4680_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ajpath.2011.05.013","volume":"179","author":"D Bettenworth","year":"2011","unstructured":"Bettenworth\u00a0D, Buyse\u00a0M, B\u00f6hm\u00a0M et\u00a0al (2011) The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function. Am J Pathol 179:1230\u20131242","journal-title":"Am J Pathol"},{"key":"4680_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ced.12203","volume":"39","author":"G Biolcati","year":"2014","unstructured":"Biolcati\u00a0G, Aurizi\u00a0C, Barbieri\u00a0L et al (2014) Efficacy of the melanocortin analogue Nle4-D-Phe7-\u03b1-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease. Clin Exp Dermatol 39:168\u2013175","journal-title":"Clin Exp Dermatol"},{"key":"4680_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1046\/j.0022-202x.2001.01704.x","volume":"118","author":"M B\u00f6hm","year":"2002","unstructured":"B\u00f6hm\u00a0M, Schiller\u00a0M, Li\u00a0Z et al (2002) Evidence for expression of melanocortin\u20111 receptor in human sebocytes in vitro and in situ. J\u00a0Invest Dermatol 118:533\u2013539","journal-title":"J Invest Dermatol"},{"key":"4680_CR6","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1074\/jbc.M312549200","volume":"279","author":"M B\u00f6hm","year":"2004","unstructured":"B\u00f6hm\u00a0M, Raghunath\u00a0M, Sunderk\u00f6tter\u00a0C et al (2004) Collagen metabolism is a\u00a0novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J\u00a0Biol Chem 279:6959\u20136966","journal-title":"J Biol Chem"},{"key":"4680_CR7","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1074\/jbc.M406334200","volume":"280","author":"M B\u00f6hm","year":"2005","unstructured":"B\u00f6hm\u00a0M, Scholzen\u00a0TE, Healy et al (2005) Alpha-melanocyte-stimulating hormone protects from UVB-induced apoptosis. J\u00a0Biol Chem 280:5795\u20135802","journal-title":"J Biol Chem"},{"key":"4680_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jaci.2011.11.012","volume":"129","author":"M B\u00f6hm","year":"2012","unstructured":"B\u00f6hm\u00a0M, Apel\u00a0M, Sugawara\u00a0K et al (2012) Modulation of basophil activity\u2014a\u00a0novel function of the neuropeptide \u03b1\u2011melanocyte-stimulating hormone. J\u00a0Allergy Clin Immunol 129:1085\u20131093","journal-title":"J Allergy Clin Immunol"},{"key":"4680_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1468-3083.2012.04658.x","volume":"28","author":"M B\u00f6hm","year":"2014","unstructured":"B\u00f6hm\u00a0M, Ehrchen\u00a0J, Luger\u00a0TA (2014) Beneficial effects of the melanocortin analogue Nle4-D-Phe7-\u03b1-MSH in acne vulgaris. J\u00a0Eur Acad Dermatol Venereol 28:108\u2013111","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4680_CR10","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1111\/jdv.13310","volume":"30","author":"M B\u00f6hm","year":"2016","unstructured":"B\u00f6hm\u00a0M, Jagirdar\u00a0K, Sturm\u00a0A et al (2016) Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a\u00a0combined high-risk MC1R\/CDKN2A genotype patient. J\u00a0Eur Acad Dermatol Venereol 30:e65\u2013e7","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4680_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/exd.13887","volume":"28","author":"M B\u00f6hm","year":"2019","unstructured":"B\u00f6hm\u00a0M, Luger\u00a0TA (2019) Are melanocortin peptides future therapeutics for cutaneous wound healing? Exp Dermatol 28:219\u2013224","journal-title":"Exp Dermatol"},{"key":"4680_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1210\/er.2007-0027","volume":"29","author":"T Brzoska","year":"2008","unstructured":"Brzoska\u00a0T, Luger\u00a0TA, Maaser\u00a0C et al (2008) \u03b1\u2011Melanocyte-stimulating hormone and related tripeptides. Biochemistry, anti-inflammatory effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29:561\u2013602","journal-title":"Endocr Rev"},{"key":"4680_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0092-8674(00)80467-5","volume":"91","author":"W Chen","year":"1997","unstructured":"Chen\u00a0W, Kelly\u00a0MA, Opitz-Araya\u00a0X et al (1997) Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91:789\u2013798","journal-title":"Cell"},{"key":"4680_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","volume":"24","author":"K Cl\u00e9ment","year":"2018","unstructured":"Cl\u00e9ment\u00a0K, Biebermann\u00a0H, Farooqi\u00a0S et\u00a0al (2018) MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency. Nat Med 24:551\u2013555","journal-title":"Nat Med"},{"key":"4680_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/pcmr.12257","volume":"27","author":"JC Garcia-Borron","year":"2014","unstructured":"Garcia-Borron\u00a0JC, Abdel-Malek\u00a0Z, Jiminez-Cervantes\u00a0C (2014) MC1R, the cAMP pathway, and the response to UV: extending the horizon beyond pigmentation. Pigment Cell Melanoma Res 27:699\u2013720","journal-title":"Pigment Cell Melanoma Res"},{"key":"4680_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/bjd.17125","volume":"180","author":"P Gkogkolou","year":"2019","unstructured":"Gkogkolou\u00a0P, Sarna\u00a0M, Sarna\u00a0T (2019) Protection of glucotoxicity by a\u00a0tripeptide derivative of alpha-melanocyte-stimulating hormone in human epidermal keratinocytes. Br J Dermatol 180:836\u2013848","journal-title":"Br J Dermatol"},{"key":"4680_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/ijd.13585","volume":"56","author":"L Habbema","year":"2017","unstructured":"Habbema\u00a0L, Halk\u00a0AB, Neumann\u00a0M et al (2017) Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a\u00a0review. Int J Dermatol 56:975\u2013980","journal-title":"Int J Dermatol"},{"key":"4680_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2133.2010.10104.x","volume":"164","author":"AK Haylett","year":"2011","unstructured":"Haylett\u00a0AK, Nie\u00a0Z, Brownrigg\u00a0M et al (2011) Systemic photoprotection in solar urticaria with \u03b1\u2011melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-\u03b1-MSH. Br J Dermatol 164:407\u2013414","journal-title":"Br J Dermatol"},{"key":"4680_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/art.24228","volume":"60","author":"A Kokot","year":"2009","unstructured":"Kokot\u00a0A, Sindrilaru\u00a0A, Schiller\u00a0M et al (2009) \u03b1\u2011Melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a\u00a0mouse model of scleroderma. Arthritis Rheum 60:592\u2013603","journal-title":"Arthritis Rheum"},{"key":"4680_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"Krude\u00a0H, Biebermann, Luck\u00a0W et al (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155\u2013157","journal-title":"Nat Genet"},{"key":"4680_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa1512693","volume":"375","author":"P K\u00fchnen","year":"2016","unstructured":"K\u00fchnen\u00a0P, Cl\u00e9ment\u00a0K, Wiegand\u00a0S et al (2016) Proopiomelanocortin deficiency treated with a\u00a0melanocortin\u20114 receptor agonist. N\u00a0Engl J Med 375:240\u2013246","journal-title":"N Engl J Med"},{"key":"4680_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.molmed.2018.12.002","volume":"25","author":"P K\u00fchnen","year":"2019","unstructured":"K\u00fchnen\u00a0P, Krude\u00a0H, Biebermann\u00a0H (2019) Melanocortin\u20114 receptor signalling: importance for weight regulation and obesity treatment. Trends Mol Med 25:136\u2013148","journal-title":"Trends Mol Med"},{"key":"4680_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MIB.0000000000001000","volume":"23","author":"T Kucharzik","year":"2017","unstructured":"Kucharzik\u00a0T, Lemmnitz\u00a0G, Abels\u00a0C et al (2017) Tripeptide K(D)PT is well tolerated in mild-to-moderate ulcerative colitis: results from a\u00a0randomized multicenter study. Inflamm Bowel Dis 23:261\u2013271","journal-title":"Inflamm Bowel Dis"},{"key":"4680_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMoa1411481","volume":"373","author":"JG Langendonk","year":"2015","unstructured":"Langendonk\u00a0JG, Balwani\u00a0M, Anderson\u00a0KE et\u00a0al (2015) Afamelanotide for erythropoietic protoporphyria. N\u00a0Engl J Med 373:48\u201359","journal-title":"N Engl J Med"},{"key":"4680_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim\u00a0HW, Grimes\u00a0PE, Agbai\u00a0O et al (2015) Afamelanotide and narrowband UV\u2011B phototherapy for the treatment of vitiligo: a\u00a0randomized multicenter trial. JAMA Dermatol 151:42\u201350","journal-title":"JAMA Dermatol"},{"key":"4680_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/exd.12250","volume":"22","author":"L-F Luo","year":"2013","unstructured":"Luo\u00a0L\u2011F, Shi\u00a0Y, Zhou\u00a0Q et al (2013) Insufficient expression of the melanocortin\u20111 receptor by human dermal fibroblasts contributes to excess collagen synthesis in keloid scars. Exp Dermatol 22:764\u2013766","journal-title":"Exp Dermatol"},{"key":"4680_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/jid.2015.16","volume":"135","author":"TA Luger","year":"2015","unstructured":"Luger\u00a0TA, B\u00f6hm\u00a0M (2015) An \u03b1\u2011MSH analogue in erythropoietic protoporphyria. J\u00a0Invest Dermatol 135:929\u2013931","journal-title":"J Invest Dermatol"},{"key":"4680_CR28","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.4049\/jimmunol.0902298","volume":"85","author":"A Mastrofrancesco","year":"2010","unstructured":"Mastrofrancesco\u00a0A, Kokot\u00a0A, Eberle\u00a0A et al (2010) KdPT, a\u00a0tripeptide derivative of \u03b1\u2011MSH, is a\u00a0suppressor of proinflammatory cytokine expression and signaling in human sebocytes. J\u00a0Immunol 85:1903\u20131911","journal-title":"J Immunol"},{"key":"4680_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s40262-016-0501-5","volume":"56","author":"EI Minder","year":"2017","unstructured":"Minder\u00a0EI, Barman-Aksoezen\u00a0J, Schneider-Yin\u00a0X (2017) Pharmacokinetics and pharmacodynamics of afamelanotide and its clinical use in treating dermatologic disorders. Clin Pharmacokinet 56:815\u2013823","journal-title":"Clin Pharmacokinet"},{"key":"4680_CR30","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1210\/en.2008-1212","volume":"150","author":"JD Spencer","year":"2009","unstructured":"Spencer\u00a0JD, Schallreuter\u00a0KU (2009) Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone\/melanocortin\u20114 receptor signaling. Endocrinology 150:1250\u20131258","journal-title":"Endocrinology"},{"key":"4680_CR31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1046\/j.1523-1747.2000.00094.x","volume":"115","author":"D Thiboutot","year":"2000","unstructured":"Thiboutot\u00a0D, Sivarajah\u00a0A, Gilliland\u00a0K et\u00a0al (2000) The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J\u00a0Invest Dermatol 115:614\u2013619","journal-title":"J Invest Dermatol"},{"key":"4680_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1749-6632.2003.tb03175.x","volume":"994","author":"L Zhang","year":"2003","unstructured":"Zhang\u00a0L, Anthonavage\u00a0M, Huang\u00a0Q et\u00a0al (2003) Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci 994:154\u2013161","journal-title":"Ann N Y Acad Sci"},{"key":"4680_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejphar.2010.10.100","volume":"660","author":"L Zhang","year":"2011","unstructured":"Zhang\u00a0L, Li\u00a0W\u2011H, Athonovage\u00a0M et al (2011) Melanocortin 5 receptor and sebogenesis. Eur J Pharmacol 660:202\u2013206","journal-title":"Eur J Pharmacol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04680-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-020-04680-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04680-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:03:38Z","timestamp":1630706618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-020-04680-6"}},"subtitle":["Grundlagen, translationale Forschung, klinische Dermatologie und Zukunftsperspektiven","Fundamentals, translational research, clinical dermatology, and future perspectives"],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4680"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04680-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"3 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0B\u00f6hm gibt an, dass er Studienleiter einer von der Firma Clinuvel gesponserten Phase-II-Studie von Afamelanotid bei Patienten mit Akne war, beratend f\u00fcr die Firma t\u00e4tig war und finanzielle Unterst\u00fctzung von der Firma f\u00fcr die Durchf\u00fchrung von Symposien \u00fcber Melanokortine erhalten hat. M.\u00a0B\u00f6hm gibt auch an, dass er finanzielle Unterst\u00fctzung von der Firma Wolff Bielefeld f\u00fcr In-vitro-Versuche zu KdPT an Keratinozyten erhalten hat. Dieser Beitrag enth\u00e4lt keine Studien am Menschen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}